Juvenile myoclonic epilepsy refractory to treatment in a tertiary referral center

[1]  S. Bayramoğlu,et al.  Evaluation of cognitive functions of juvenile myoclonic epileptic patients by magnetic resonance spectroscopy and neuropsychiatric cognitive tests concurrently , 2016, Neurological Sciences.

[2]  M. Brodie,et al.  Pharmacological outcomes in juvenile myoclonic epilepsy: Support for sodium valproate , 2016, Epilepsy Research.

[3]  K. Valente,et al.  Delineating behavioral and cognitive phenotypes in juvenile myoclonic epilepsy: Are we missing the forest for the trees? , 2016, Epilepsy & Behavior.

[4]  Young-Min Shon,et al.  Extrafrontal structural changes in juvenile myoclonic epilepsy: A topographic analysis of combined structural and microstructural brain imaging , 2015, Seizure.

[5]  S. Duncan,et al.  Neuropsychological profiles of patients with juvenile myoclonic epilepsy and their siblings: An extended study , 2015, Epilepsia.

[6]  E. Trinka,et al.  Seizure outcome in 175 patients with juvenile myoclonic epilepsy – A long-term observational study , 2014, Epilepsy Research.

[7]  K. Hamandi,et al.  Hyperconnectivity in juvenile myoclonic epilepsy: A network analysis , 2014, NeuroImage: Clinical.

[8]  Wendyl D'Souza,et al.  Focal abnormalities in idiopathic generalized epilepsy: A critical review of the literature , 2014, Epilepsia.

[9]  John S. Duncan,et al.  Motor co-activation in siblings of patients with juvenile myoclonic epilepsy: an imaging endophenotype? , 2014, Brain : a journal of neurology.

[10]  Walter Paulus,et al.  Idiopathic‐generalized epilepsy shows profound white matter diffusion—tensor imaging alterations , 2014, Human brain mapping.

[11]  W. D’Souza,et al.  Cognitive functioning in idiopathic generalised epilepsies: A systematic review and meta-analysis , 2014, Neuroscience & Biobehavioral Reviews.

[12]  Seong-Beom Koh,et al.  Altered thalamocortical functional connectivity in idiopathic generalized epilepsy , 2014, Epilepsia.

[13]  C. Kessler,et al.  Clinical predictors of the long‐term social outcome and quality of life in juvenile myoclonic epilepsy: 20–65 years of follow‐up , 2014, Epilepsia.

[14]  B. Schmitz,et al.  Prognosis of juvenile myoclonic epilepsy 45 years after onset , 2013, Neurology.

[15]  René Andrade Machado,et al.  Efficacy and tolerability of lamotrigine in Juvenile Myoclonic Epilepsy in adults: A prospective, unblinded randomized controlled trial , 2013, Seizure.

[16]  C. Whelan,et al.  Regional increase of cerebral cortex thickness in juvenile myoclonic epilepsy , 2013, Epilepsia.

[17]  K. Park,et al.  A randomized open-label observational study to compare the efficacy and tolerability between topiramate and valproate in juvenile myoclonic epilepsy , 2013, Journal of Clinical Neuroscience.

[18]  M. Trimble,et al.  Neuropsychology and behavior in juvenile myoclonic epilepsy , 2013, Epilepsy & Behavior.

[19]  M. T. Medina,et al.  Consensus on diagnosis and management of JME: From founder's observations to current trends , 2013, Epilepsy & Behavior.

[20]  M. Koepp,et al.  Frontal lobe function and structure in juvenile myoclonic epilepsy: A comprehensive review of neuropsychological and imaging data , 2012, Epilepsia.

[21]  John S. Duncan,et al.  Abnormal thalamocortical structural and functional connectivity in juvenile myoclonic epilepsy , 2012, Brain : a journal of neurology.

[22]  H. Seol,et al.  Microstructural white matter abnormality and frontal cognitive dysfunctions in juvenile myoclonic epilepsy , 2012, Epilepsia.

[23]  C. Kessler,et al.  Predictors for long‐term seizure outcome in juvenile myoclonic epilepsy: 25–63 years of follow‐up , 2012, Epilepsia.

[24]  Khalid Hamandi,et al.  Understanding juvenile myoclonic epilepsy: Contributions from neuroimaging , 2011, Epilepsy Research.

[25]  Kátia Lin,et al.  Prognosis of juvenile myoclonic epilepsy is related to endophenotypes , 2011, Seizure.

[26]  P. Cossette Channelopathies and juvenile myoclonic epilepsy , 2010, Epilepsia.

[27]  S. Moshé,et al.  Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies , 2009, Epilepsia.

[28]  P. Camfield,et al.  Juvenile myoclonic epilepsy 25 years after seizure onset , 2009, Neurology.

[29]  C. Gurses,et al.  Myoclonic seizures subside in the fourth decade in juvenile myoclonic epilepsy , 2008, Neurology.

[30]  Jing Shen,et al.  The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial , 2007, The Lancet.

[31]  M. T. Medina,et al.  Juvenile myoclonic epilepsy subsyndromes: family studies and long-term follow-up. , 2006, Brain : a journal of neurology.

[32]  E. Wirrell,et al.  Prognostic Significance of Failure of the Initial Antiepileptic Drug in Children with Absence Epilepsy , 2001, Epilepsia.

[33]  Jerome Engel,et al.  A Proposed Diagnostic Scheme for People with Epileptic Seizures and with Epilepsy: Report of the ILAE Task Force on Classification and Terminology , 2001, Epilepsia.

[34]  D. Janz,et al.  Epilepsy with impulsive petit mal (Juvenile Myoclonic Epilepsy) , 1985, Acta neurologica Scandinavica.

[35]  W. Christian,et al.  Impulsiv-Petit mal , 1957, Deutsche Zeitschrift für Nervenheilkunde.

[36]  C. D. Marco,et al.  L'EPILESSIA MIOCLONICA GIOVANILE DI JANZ: ANALISI PROSPETTICA DI UN CAMPIONE DI 57 PAZIENTI , 1990 .